Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Microglia-Mediated Synapse Loss in Alzheimer's Disease.

Rajendran L, Paolicelli RC.

J Neurosci. 2018 Mar 21;38(12):2911-2919. doi: 10.1523/JNEUROSCI.1136-17.2017.

2.

Alzheimer's Disease and Sleep-Wake Disturbances: Amyloid, Astrocytes, and Animal Models.

Vanderheyden WM, Lim MM, Musiek ES, Gerstner JR.

J Neurosci. 2018 Mar 21;38(12):2901-2910. doi: 10.1523/JNEUROSCI.1135-17.2017.

3.

Molecular Mechanisms of Synaptotoxicity and Neuroinflammation in Alzheimer's Disease.

Marttinen M, Takalo M, Natunen T, Wittrahm R, Gabbouj S, Kemppainen S, Leinonen V, Tanila H, Haapasalo A, Hiltunen M.

Front Neurosci. 2018 Dec 14;12:963. doi: 10.3389/fnins.2018.00963. eCollection 2018. Review.

4.

TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss.

Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, Lee EB, Rose J, Appel S, Lee VM, Trojanowski JQ, Spires-Jones T, Schulz PE, Rajendran L.

Neuron. 2017 Jul 19;95(2):297-308.e6. doi: 10.1016/j.neuron.2017.05.037. Epub 2017 Jun 29.

5.

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Lian H, Litvinchuk A, Chiang AC, Aithmitti N, Jankowsky JL, Zheng H.

J Neurosci. 2016 Jan 13;36(2):577-89. doi: 10.1523/JNEUROSCI.2117-15.2016.

6.

Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.

Martin E, Boucher C, Fontaine B, Delarasse C.

Aging Cell. 2017 Feb;16(1):27-38. doi: 10.1111/acel.12522. Epub 2016 Oct 8.

7.

Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.

Shukuri M, Mawatari A, Ohno M, Suzuki M, Doi H, Watanabe Y, Onoe H.

J Nucl Med. 2016 Feb;57(2):291-6. doi: 10.2967/jnumed.115.166116. Epub 2015 Nov 19.

8.
9.

Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?

Piirainen S, Youssef A, Song C, Kalueff AV, Landreth GE, Malm T, Tian L.

Neurosci Biobehav Rev. 2017 Jun;77:148-164. doi: 10.1016/j.neubiorev.2017.01.046. Epub 2017 Feb 6. Review.

PMID:
28185874
10.

Do Microglia Default on Network Maintenance in Alzheimer's Disease?

Southam KA, Vincent AJ, Small DH.

J Alzheimers Dis. 2016;51(3):657-69. doi: 10.3233/JAD-151075. Review.

11.

[Alzheimer's disease: new prospects in therapy and applied experimental models].

Kubis AM, Janusz M.

Postepy Hig Med Dosw (Online). 2008 Aug 5;62:372-92. Review. Polish.

12.

New insights on the role of microglia in synaptic pruning in health and disease.

Hong S, Dissing-Olesen L, Stevens B.

Curr Opin Neurobiol. 2016 Feb;36:128-34. doi: 10.1016/j.conb.2015.12.004. Epub 2015 Dec 30. Review.

13.

Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease.

Xie J, Wang H, Lin T, Bi B.

Biomed Res Int. 2017;2017:2986460. doi: 10.1155/2017/2986460. Epub 2017 Apr 3. Review.

14.

Expression Pattern of Scavenger Receptors and Amyloid-β Phagocytosis of Astrocytes and Microglia in Culture are Modified by Acidosis: Implications for Alzheimer's Disease.

Eugenín J, Vecchiola A, Murgas P, Arroyo P, Cornejo F, von Bernhardi R.

J Alzheimers Dis. 2016 May 30;53(3):857-73. doi: 10.3233/JAD-160083.

PMID:
27258416
15.

Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction.

Orre M, Kamphuis W, Osborn LM, Jansen AHP, Kooijman L, Bossers K, Hol EM.

Neurobiol Aging. 2014 Dec;35(12):2746-2760. doi: 10.1016/j.neurobiolaging.2014.06.004. Epub 2014 Jun 14.

PMID:
25002035
16.

Astrocytes and neuroinflammation in Alzheimer's disease.

Phillips EC, Croft CL, Kurbatskaya K, O'Neill MJ, Hutton ML, Hanger DP, Garwood CJ, Noble W.

Biochem Soc Trans. 2014 Oct;42(5):1321-5. doi: 10.1042/BST20140155.

PMID:
25233410
17.

Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.

Landlinger C, Oberleitner L, Gruber P, Noiges B, Yatsyk K, Santic R, Mandler M, Staffler G.

J Neuroinflammation. 2015 Aug 16;12:150. doi: 10.1186/s12974-015-0369-6.

18.

CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

Lee S, Varvel NH, Konerth ME, Xu G, Cardona AE, Ransohoff RM, Lamb BT.

Am J Pathol. 2010 Nov;177(5):2549-62. doi: 10.2353/ajpath.2010.100265. Epub 2010 Sep 23.

19.

Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.

Streit WJ, Braak H, Xue QS, Bechmann I.

Acta Neuropathol. 2009 Oct;118(4):475-85. doi: 10.1007/s00401-009-0556-6. Epub 2009 Jun 10.

20.

Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Montgomery SL, Mastrangelo MA, Habib D, Narrow WC, Knowlden SA, Wright TW, Bowers WJ.

Am J Pathol. 2011 Oct;179(4):2053-70. doi: 10.1016/j.ajpath.2011.07.001. Epub 2011 Aug 9.

Supplemental Content

Support Center